
501 - 1000 employees
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $50M Post-IPO Equity on 2026-07
Biotechnology • Pharmaceuticals
MannKind is a biopharmaceutical company focused on transforming chronic disease care through patient-centric drug and drug‑device combination therapies. The company develops and commercializes treatments for cardiometabolic and orphan lung diseases — including diabetes, pulmonary hypertension, and fluid overload related to heart failure and chronic kidney disease — and has expertise in inhalation delivery technologies (e. g. , the Afrezza inhaled insulin product and related Technosphere platform). MannKind is publicly traded (Nasdaq: MNKD) and emphasizes therapies designed to fit seamlessly into patients’ daily lives.
📡 We watch MannKind Corporation's careers page
Several times a day
how often we check
2
roles posted in the last 30 days
Selected: 🆕 Date Added.
🔥 1 minute ago
National Account Director securing formulary access and payer partnerships for MannKind’s biopharmaceutical treatments. Managing national accounts, launches, market access strategy, and cross-functional execution.
🇺🇸 United States – Remote
💵 $184k - $276k / year
🔥 Funding within the last year
💰 $50M Post-IPO Equity on 2026-07
⏰ Full Time
🔴 Lead
🧑💼 Account Executive
👻 Ghost score 0%
🔥 1 minute ago
Cardiology MSL advancing scientific engagement and medical strategy for MannKind’s cardiometabolic therapies. Supporting KOLs, research initiatives, education, and evidence-based patient care across the North Region.
🌽 Illinois, Iowa, +8 more states – Remote
💵 $148k - $222k / year
🔥 Funding within the last year
💰 $50M Post-IPO Equity on 2026-07
⏰ Full Time
🟡 Mid-level
🟠 Senior
✨ Medical Science Liaison
👻 Ghost score 0%